outcome

You have access
Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor
KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, KAZUHIRO YOSHIDA, TOMOKAZU FUJI, KENJIRO KUMANO, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA

Anticancer Research May 2022, 42 (5) 2797-2801; DOI: https://doi.org/10.21873/anticanres.15760
You have access
Systematic Review on the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Esophagectomy for Esophageal Cancer
KOSEI TAKAGI, STEFAN BUETTNER, JAN N.M. IJZERMANS and BAS P.L. WIJNHOVEN

Anticancer Research October 2020, 40 (10) 5343-5349; DOI: https://doi.org/10.21873/anticanres.14541
You have access
Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors
ONDREJ FIALA, ONDREJ SOREJS, JAN SUSTR, RADEK KUCERA, ONDREJ TOPOLCAN and JINDRICH FINEK

Anticancer Research March 2020, 40 (3) 1219-1227; DOI: https://doi.org/10.21873/anticanres.14063
You have access
Radiotherapy Does Not Impact Long-term Function Following Resection of Soft-tissue Sarcomas of the Hand
NICHOLAS F. MUNARETTO, ANTHONY L. LOGLI, PETER S. ROSE, IVY A. PETERSEN, SAFIA K. AHMED, KARIM BAKRI, STEVEN L. MORAN and MATTHEW T. HOUDEK

Anticancer Research March 2020, 40 (3) 1463-1466; DOI: https://doi.org/10.21873/anticanres.14089
You have access
Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database
HUSSEIN A. ASSI, SARBAJIT MUKHERJEE, MICHAEL MACHIORLATTI, SARA VESELY, VIPUL PAREEK and HASSAN HATOUM

Anticancer Research February 2020, 40 (2) 847-855; DOI: https://doi.org/10.21873/anticanres.14017
You have access
Is there a Role for the Appleby Procedure in 2020? Results from a Matched-Pair-Analysis
THOMAS MALINKA, LEA TIMMERMANN, FRITZ KLEIN, DOMINIK GEISEL, JOHANN PRATSCHKE and MARCUS BAHRA

Anticancer Research January 2020, 40 (1) 387-392; DOI: https://doi.org/10.21873/anticanres.13964
You have access
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors
ANGELIKA TERBUCH, FLORIAN POSCH, THOMAS BAUERNHOFER, MARTIN PICHLER, HEIDI PEINSITH, JOANNA SZKANDERA, JAKOB RIEDL, GEORG C. HUTTERER, KARL PUMMER, RICHARD PARTL, KARIN S. KAPP, HERBERT STÖGER, MICHAEL STOTZ and ARMIN GERGER

Anticancer Research October 2019, 39 (10) 5589-5596; DOI: https://doi.org/10.21873/anticanres.13753
You have access
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
SUGURU SHIROTAKE, KIMIHARU TAKAMATSU, RYUICHI MIZUNO, GO KANEKO, KOSHIRO NISHIMOTO, MOTOTSUGU OYA and MASAFUMI OYAMA

Anticancer Research August 2019, 39 (8) 4371-4377; DOI: https://doi.org/10.21873/anticanres.13606
You have access
Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional Study
MASAKI SHIOTA, MOTONOBU NAKAMURA, AKIRA YOKOMIZO, TOSHIHISA TOMODA, NAOTAKA SAKAMOTO, NARIHITO SEKI, SHUJI HASEGAWA, TAKAKAZU YUNOKI, MASAHIKO HARANO, KENTARO KUROIWA and MASATOSHI ETO

Anticancer Research August 2019, 39 (8) 4411-4414; DOI: https://doi.org/10.21873/anticanres.13612
You have access
Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation
HEINRICH M.L. MÜHLHOFER, ULRICH LENZE, ALEXANDRA GERSING, VINCENT LALLINGER, RAINER BURGKART, ANDREAS OBERMEIER, RÜDIGER VON EISENHART-ROTHE and CAROLIN KNEBEL

Anticancer Research June 2019, 39 (6) 2985-2992; DOI: https://doi.org/10.21873/anticanres.13430

Main menu

User menu

Search

outcome

Pages